Table 2.
Association of peak TRF length with the clinicopathological features of tumors.
| Peak TRF length →(in kbp) | Malignant tissue (N = 85) | Adjacent normal tissue (N = 85) |
|---|---|---|
| Age groups | ||
| I | 8.18 | 9.6 |
| II | 7.87 | 10.11 |
| III | 8.60 | 10.4 |
| Tumor differentiation | ||
| Well | 7.7 | 10.23 |
| Moderate | 8.35 | 9.53 |
| Poor | 9.51 | 10.1 |
| Disease Stage | ||
| Stage 1 | 6.75 | 7.34 |
| Stage 2 | 7.72 | 9.27 |
| Stage 3 | 10.1 | 10.01 |
| Stage 4 | 8.28 | 9.35 |
| Nuclear grade | ||
| I | 7.47 | 10.04 |
| II | 8.42 | 9.32 |
| III | 9.13 | 10.75 |
| Tumor size | ||
| T1 | 8.11 | 8.23 |
| T2 | 8.08 | 9.27 |
| T3 | 9.30 | 10.30 |
| T4 | 7.94 | 10.44 |
| Lymph node status | ||
| Positive | 8.0 | 9.23 |
| Negative | 8.45 | 10.38 |